Welcome
Support Centre
11 February 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
Effects of hand-held paddle electrodes and biphasic shocks on the outcome of external cardioversion of atrial fibrillation
ISRCTN ISRCTN42858989
ClinicalTrials.gov identifier
Public title Effects of hand-held paddle electrodes and biphasic shocks on the outcome of external cardioversion of atrial fibrillation
Scientific title
Acronym MOBIPAPA
Serial number at source N/A
Study hypothesis A randomised trial to assess the effects of biphasic shocks in combination with an anterior-posterior electrode position and the effect of hand-held shock electrodes on external electrical cardioversion outcome.
Lay summary
Ethics approval Not provided at time of registration
Study design Randomised controlled trial
Countries of recruitment Germany
Disease/condition/study domain Atrial fibrillation
Participants - inclusion criteria All patients presenting with persistent atrial fibrillation and an indication for external cardioversion in the Department of Cardiology of the University Hospital Münster, Germany were consecutively screened for the trial.

Inclusion criteria:
1. A clinical indication for external cardioversion of atrial fibrillation
2. Documented atrial fibrillation prior to the procedure
3. To minimise thrombo-embolic complications, documented oral anticoagulation with phenprocoumon (international normalised ratio [INR] 2 - 3) for three weeks or exclusion of left atrial thrombi by trans-oesophageal echocardiography directly prior to the cardioversion procedure was required. Continuation of anticoagulation after cardioversion was recommended for all trial patients.
Participants - exclusion criteria Patients presenting with atrial flutter or atrial tachycardias
Anticipated start date 01/01/2004
Anticipated end date 01/01/2005
Status of trial Completed
Patient information material
Target number of participants 200
Interventions With an assumed success rate of the monophasic shock wave form between 79% and 90%, we calculated a group size of 100 patients per group to achieve a statistical power of 0.8 (beta error 0.2) and a two-sided alpha level of 0.05 for each of the two hypotheses.

All shocks were delivered in an anterior-posterior electrode position. Patients were anaesthetised using standard procedures (either propofol or etomidate in combination with opioid analgetics). The trial was designed to detect an absolute difference in cardioversion success rate of 10% between two different shock wave forms (monophasic/biphasic) and between two different electrode types (hand-held paddle electrodes/adhesive patch electrodes).

Due to training-dependent quality of the positioning of the cardioversion electrodes, a sequential design for the comparison of patch and paddle electrodes was chosen, while the simple exchange of the monophasic and biphasic defibrillators was tested in a randomised design.
Primary outcome measure(s) Successful restoration of sinus rhythm by the cardioversion shock.
Secondary outcome measure(s) Not provided at time of registration
Sources of funding 1. University Hospital Münster (Germany) - Department of Cardiology
2. Medtronic Inc (Germany)
Trial website
Publications
Contact name Dr  Paulus  Kirchhof
  Address Department of Cardiology and Angiology
University Hospital Münster
Albert-Schweitzer-Straße 33
  City/town Münster
  Zip/Postcode 48129
  Country Germany
  Tel +49 (0)251 8347638
  Fax +49 (0)251 8347864
  Email kirchhp@uni-muenster.de
Sponsor University Hospital Münster (Germany)
  Address Albert-Schweitzer-Straße 33
  City/town Münster
  Zip/Postcode D-48129
  Country Germany
Date applied 15/06/2004
Last edited 05/11/2008
Date ISRCTN assigned 31/01/2005
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central